AxoSim empowers advancements in human neuroscience by partnering with biopharma companies to facilitate breakthroughs in devastating neurological diseases and disorders. Their proprietary drug discovery platforms NerveSim®, BrainSim®, and microBrain™ deliver clinically-relevant data to select better lead candidates with phenotypically accurate assays. AxoSim's platforms have applications in peripheral neuropathy and neuropathic pain, disease modeling (such as ALS, MS, and CMT), and neurotoxicology. Is your organization interested in learning more about what we do? Please email us at info@axosim.com.
View Top Employees from AxoSimWebsite | http://www.axosim.com |
Revenue | $5 million |
Funding | $150000 |
Employees | 34 (33 on RocketReach) |
Founded | 2014 |
Address | 1441 Canal Street, New Orleans, Louisiana 70112, US |
Phone | (504) 407-7419 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biopharma, Drug Developent, Business Services, Biotechnology, Preclinical Testing, Health Care, Neurotoxicity, Science and Engineering, Neuroefficacy, Life Science, 3D Cell Assays, Medical, Neuroscience, Pharmaceutical |
Web Rank | 9 Million |
Keywords | Axosim, Axosim Images, Axomsim |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular AxoSim employee's phone or email?
The AxoSim annual revenue was $5 million in 2024.
Benjamin Cappiello is the Chief Business Officer of AxoSim.
33 people are employed at AxoSim.
AxoSim is based in New Orleans, Louisiana.
The NAICS codes for AxoSim are [541, 5417, 54171, 54, 541714].
The SIC codes for AxoSim are [87, 873].